Report Detail

Medical Devices & Consumables Global Pulmonary Embolectomy System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4708593
  • |
  • 17 June, 2026
  • |
  • Global
  • |
  • 121 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Pulmonary Embolectomy System market size was valued at US$ 1142 million in 2025 and is forecast to a readjusted size of US$ 1895 million by 2032 with a CAGR of 7.5% during review period.
Pulmonary embolectomy systems are specialized medical devices designed for the minimally invasive removal of thromboemboli from the pulmonary arteries to restore hemodynamic stability in patients with acute pulmonary embolism. These systems typically comprise aspiration catheters, mechanical thrombectomy devices, guidewires, and negative pressure aspiration pumps. Unlike traditional surgical embolectomy, catheter-based techniques achieve thrombus removal through percutaneous access, offering reduced procedural trauma, shorter hospital stays, and improved clinical outcomes for intermediate- and high-risk patients. Key technologies include large-bore aspiration catheters, mechanical fragmentation devices, and rheolytic thrombectomy systems. From a value chain perspective, upstream includes catheter material suppliers (medical-grade polymers, braiding wires), guidewire component manufacturers, aspiration pump and console producers, and packaging/sterilization service providers; midstream involves device assembly, quality control, regulatory certification (FDA, CE, NMPA), and distribution; downstream demand spans interventional cardiology departments, vascular surgery departments, interventional radiology departments, and intensive care units in hospitals. In 2025, the average selling price is approximately US$9,800 per unit, global sales volume is about 113.3k units, and gross margins generally range from 50% to 70%, driven by catheter material costs, device design complexity, regulatory approval barriers, and physician training requirements.
The pulmonary embolectomy system market is experiencing robust growth driven by the increasing global incidence of pulmonary embolism and the paradigm shift toward minimally invasive catheter-based interventions over traditional surgical embolectomy. According to the CDC, approximately 900,000 people in the United States are affected by deep vein thrombosis and pulmonary embolism annually, with about 60,000-100,000 deaths. This high disease burden, coupled with the availability of effective mechanical thrombectomy devices, has created substantial demand for pulmonary embolectomy systems.
Another key trend is the expansion of treatment guidelines that now recommend catheter-directed therapies for intermediate-risk pulmonary embolism patients. Previously, systemic anticoagulation was the standard of care for non-massive PE, but growing evidence supports the use of mechanical thrombectomy to reduce right ventricular strain, improve long-term functional outcomes, and prevent chronic thromboembolic pulmonary hypertension. This guideline expansion has significantly broadened the addressable patient population for pulmonary embolectomy systems.
The market is also witnessing significant technological innovation in next-generation thrombectomy devices. Key trends include the development of dual-action devices combining aspiration and mechanical fragmentation, enhanced navigability through complex pulmonary arterial anatomy, and real-time pressure monitoring for safer aspiration. These innovations are improving procedural efficienc
This report is a detailed and comprehensive analysis for global Pulmonary Embolectomy System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pulmonary Embolectomy System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pulmonary Embolectomy System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pulmonary Embolectomy System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pulmonary Embolectomy System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pulmonary Embolectomy System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pulmonary Embolectomy System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Inari Medical, Inc., Penumbra, Inc., Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, Johnson & Johnson (Ethicon), Terumo Corporation, Kaneka Corporation, MicroPort Scientific Corporation, Lepu Medical Technology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pulmonary Embolectomy System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Large-Bore Aspiration Catheter (> 12F)
Medium-Bore Aspiration Catheter (8-12F)
Small-Bore Aspiration Catheter (< 8F)
Market segment by Price Tier
Standard (< US$7,000)
Premium (US$7,000-15,000)
Integrated System (> US$15,000)
Market segment by Patient Risk Stratification
High-Risk PE (Massive)
Intermediate-Risk PE (Submassive)
Low-Risk PE
Market segment by Application
Tertiary / Academic Medical Center
Regional / Community Hospital
Specialized Cardiovascular Center
Major players covered
Inari Medical, Inc.
Penumbra, Inc.
Boston Scientific Corporation
Medtronic plc
Teleflex Incorporated
Johnson & Johnson (Ethicon)
Terumo Corporation
Kaneka Corporation
MicroPort Scientific Corporation
Lepu Medical Technology Co., Ltd.
Avinger, Inc.
Argon Medical Devices
Control Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Embolectomy System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pulmonary Embolectomy System, with price, sales quantity, revenue, and global market share of Pulmonary Embolectomy System from 2021 to 2026.
Chapter 3, the Pulmonary Embolectomy System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Embolectomy System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pulmonary Embolectomy System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pulmonary Embolectomy System.
Chapter 14 and 15, to describe Pulmonary Embolectomy System sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pulmonary Embolectomy System Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Large-Bore Aspiration Catheter (> 12F)
    • 1.3.3 Medium-Bore Aspiration Catheter (8-12F)
    • 1.3.4 Small-Bore Aspiration Catheter (< 8F)
  • 1.4 Market Analysis by Price Tier
    • 1.4.1 Overview: Global Pulmonary Embolectomy System Consumption Value by Price Tier: 2021 Versus 2025 Versus 2032
    • 1.4.2 Standard (< US$7,000)
    • 1.4.3 Premium (US$7,000-15,000)
    • 1.4.4 Integrated System (> US$15,000)
  • 1.5 Market Analysis by Patient Risk Stratification
    • 1.5.1 Overview: Global Pulmonary Embolectomy System Consumption Value by Patient Risk Stratification: 2021 Versus 2025 Versus 2032
    • 1.5.2 High-Risk PE (Massive)
    • 1.5.3 Intermediate-Risk PE (Submassive)
    • 1.5.4 Low-Risk PE
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Pulmonary Embolectomy System Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Tertiary / Academic Medical Center
    • 1.6.3 Regional / Community Hospital
    • 1.6.4 Specialized Cardiovascular Center
  • 1.7 Global Pulmonary Embolectomy System Market Size & Forecast
    • 1.7.1 Global Pulmonary Embolectomy System Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Pulmonary Embolectomy System Sales Quantity (2021-2032)
    • 1.7.3 Global Pulmonary Embolectomy System Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Inari Medical, Inc.
    • 2.1.1 Inari Medical, Inc. Details
    • 2.1.2 Inari Medical, Inc. Major Business
    • 2.1.3 Inari Medical, Inc. Pulmonary Embolectomy System Product and Services
    • 2.1.4 Inari Medical, Inc. Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Inari Medical, Inc. Recent Developments/Updates
  • 2.2 Penumbra, Inc.
    • 2.2.1 Penumbra, Inc. Details
    • 2.2.2 Penumbra, Inc. Major Business
    • 2.2.3 Penumbra, Inc. Pulmonary Embolectomy System Product and Services
    • 2.2.4 Penumbra, Inc. Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Penumbra, Inc. Recent Developments/Updates
  • 2.3 Boston Scientific Corporation
    • 2.3.1 Boston Scientific Corporation Details
    • 2.3.2 Boston Scientific Corporation Major Business
    • 2.3.3 Boston Scientific Corporation Pulmonary Embolectomy System Product and Services
    • 2.3.4 Boston Scientific Corporation Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Boston Scientific Corporation Recent Developments/Updates
  • 2.4 Medtronic plc
    • 2.4.1 Medtronic plc Details
    • 2.4.2 Medtronic plc Major Business
    • 2.4.3 Medtronic plc Pulmonary Embolectomy System Product and Services
    • 2.4.4 Medtronic plc Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Medtronic plc Recent Developments/Updates
  • 2.5 Teleflex Incorporated
    • 2.5.1 Teleflex Incorporated Details
    • 2.5.2 Teleflex Incorporated Major Business
    • 2.5.3 Teleflex Incorporated Pulmonary Embolectomy System Product and Services
    • 2.5.4 Teleflex Incorporated Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Teleflex Incorporated Recent Developments/Updates
  • 2.6 Johnson & Johnson (Ethicon)
    • 2.6.1 Johnson & Johnson (Ethicon) Details
    • 2.6.2 Johnson & Johnson (Ethicon) Major Business
    • 2.6.3 Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Product and Services
    • 2.6.4 Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Johnson & Johnson (Ethicon) Recent Developments/Updates
  • 2.7 Terumo Corporation
    • 2.7.1 Terumo Corporation Details
    • 2.7.2 Terumo Corporation Major Business
    • 2.7.3 Terumo Corporation Pulmonary Embolectomy System Product and Services
    • 2.7.4 Terumo Corporation Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Terumo Corporation Recent Developments/Updates
  • 2.8 Kaneka Corporation
    • 2.8.1 Kaneka Corporation Details
    • 2.8.2 Kaneka Corporation Major Business
    • 2.8.3 Kaneka Corporation Pulmonary Embolectomy System Product and Services
    • 2.8.4 Kaneka Corporation Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Kaneka Corporation Recent Developments/Updates
  • 2.9 MicroPort Scientific Corporation
    • 2.9.1 MicroPort Scientific Corporation Details
    • 2.9.2 MicroPort Scientific Corporation Major Business
    • 2.9.3 MicroPort Scientific Corporation Pulmonary Embolectomy System Product and Services
    • 2.9.4 MicroPort Scientific Corporation Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 MicroPort Scientific Corporation Recent Developments/Updates
  • 2.10 Lepu Medical Technology Co., Ltd.
    • 2.10.1 Lepu Medical Technology Co., Ltd. Details
    • 2.10.2 Lepu Medical Technology Co., Ltd. Major Business
    • 2.10.3 Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Product and Services
    • 2.10.4 Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Lepu Medical Technology Co., Ltd. Recent Developments/Updates
  • 2.11 Avinger, Inc.
    • 2.11.1 Avinger, Inc. Details
    • 2.11.2 Avinger, Inc. Major Business
    • 2.11.3 Avinger, Inc. Pulmonary Embolectomy System Product and Services
    • 2.11.4 Avinger, Inc. Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Avinger, Inc. Recent Developments/Updates
  • 2.12 Argon Medical Devices
    • 2.12.1 Argon Medical Devices Details
    • 2.12.2 Argon Medical Devices Major Business
    • 2.12.3 Argon Medical Devices Pulmonary Embolectomy System Product and Services
    • 2.12.4 Argon Medical Devices Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Argon Medical Devices Recent Developments/Updates
  • 2.13 Control Medical Technology
    • 2.13.1 Control Medical Technology Details
    • 2.13.2 Control Medical Technology Major Business
    • 2.13.3 Control Medical Technology Pulmonary Embolectomy System Product and Services
    • 2.13.4 Control Medical Technology Pulmonary Embolectomy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Control Medical Technology Recent Developments/Updates

3 Competitive Environment: Pulmonary Embolectomy System by Manufacturer

  • 3.1 Global Pulmonary Embolectomy System Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Pulmonary Embolectomy System Revenue by Manufacturer (2021-2026)
  • 3.3 Global Pulmonary Embolectomy System Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Pulmonary Embolectomy System by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Pulmonary Embolectomy System Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Pulmonary Embolectomy System Manufacturer Market Share in 2025
  • 3.5 Pulmonary Embolectomy System Market: Overall Company Footprint Analysis
    • 3.5.1 Pulmonary Embolectomy System Market: Region Footprint
    • 3.5.2 Pulmonary Embolectomy System Market: Company Product Type Footprint
    • 3.5.3 Pulmonary Embolectomy System Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pulmonary Embolectomy System Market Size by Region
    • 4.1.1 Global Pulmonary Embolectomy System Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Pulmonary Embolectomy System Consumption Value by Region (2021-2032)
    • 4.1.3 Global Pulmonary Embolectomy System Average Price by Region (2021-2032)
  • 4.2 North America Pulmonary Embolectomy System Consumption Value (2021-2032)
  • 4.3 Europe Pulmonary Embolectomy System Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Pulmonary Embolectomy System Consumption Value (2021-2032)
  • 4.5 South America Pulmonary Embolectomy System Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Pulmonary Embolectomy System Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Pulmonary Embolectomy System Sales Quantity by Type (2021-2032)
  • 5.2 Global Pulmonary Embolectomy System Consumption Value by Type (2021-2032)
  • 5.3 Global Pulmonary Embolectomy System Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Pulmonary Embolectomy System Sales Quantity by Application (2021-2032)
  • 6.2 Global Pulmonary Embolectomy System Consumption Value by Application (2021-2032)
  • 6.3 Global Pulmonary Embolectomy System Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Pulmonary Embolectomy System Sales Quantity by Type (2021-2032)
  • 7.2 North America Pulmonary Embolectomy System Sales Quantity by Application (2021-2032)
  • 7.3 North America Pulmonary Embolectomy System Market Size by Country
    • 7.3.1 North America Pulmonary Embolectomy System Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Pulmonary Embolectomy System Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Pulmonary Embolectomy System Sales Quantity by Type (2021-2032)
  • 8.2 Europe Pulmonary Embolectomy System Sales Quantity by Application (2021-2032)
  • 8.3 Europe Pulmonary Embolectomy System Market Size by Country
    • 8.3.1 Europe Pulmonary Embolectomy System Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Pulmonary Embolectomy System Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pulmonary Embolectomy System Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Pulmonary Embolectomy System Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Pulmonary Embolectomy System Market Size by Region
    • 9.3.1 Asia-Pacific Pulmonary Embolectomy System Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Pulmonary Embolectomy System Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Pulmonary Embolectomy System Sales Quantity by Type (2021-2032)
  • 10.2 South America Pulmonary Embolectomy System Sales Quantity by Application (2021-2032)
  • 10.3 South America Pulmonary Embolectomy System Market Size by Country
    • 10.3.1 South America Pulmonary Embolectomy System Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Pulmonary Embolectomy System Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pulmonary Embolectomy System Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Pulmonary Embolectomy System Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Pulmonary Embolectomy System Market Size by Country
    • 11.3.1 Middle East & Africa Pulmonary Embolectomy System Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Pulmonary Embolectomy System Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Pulmonary Embolectomy System Market Drivers
  • 12.2 Pulmonary Embolectomy System Market Restraints
  • 12.3 Pulmonary Embolectomy System Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pulmonary Embolectomy System and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pulmonary Embolectomy System
  • 13.3 Pulmonary Embolectomy System Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pulmonary Embolectomy System Typical Distributors
  • 14.3 Pulmonary Embolectomy System Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pulmonary Embolectomy System. Industry analysis & Market Report on Pulmonary Embolectomy System is a syndicated market report, published as Global Pulmonary Embolectomy System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pulmonary Embolectomy System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report